This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Progen Pharmaceuticals, Inc., Alchemia Limited, The Australian National University. Active years: 2007-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sunnybank, AU (2007 - 2012)
- Eight Mile Plains, AU (2012 - 2014)
Company Filing History:

Years Active: 2007-2014
Title: Innovations and Contributions of Inventor Ligong Liu
Introduction
Ligong Liu is a notable inventor based in Sunnybank, Australia. He has made significant contributions to the field of pharmaceuticals and biochemistry, holding a total of five patents. His work focuses on developing novel compounds that have various therapeutic applications.
Latest Patents
One of Liu's latest patents is for sulfated oligosaccharide derivatives. This invention relates to novel compounds that serve as inhibitors of heparan sulfate-binding proteins. The compounds and their compositions are intended for use in antiangiogenic, antimetastatic, anti-inflammatory, antimicrobial, anticoagulant, and/or antithrombotic treatments in mammalian subjects. Another significant patent involves derivatives of monosaccharides for drug discovery. This patent introduces new compounds and methods for preparing combinatorial libraries of potentially biologically active compounds based on monosaccharides.
Career Highlights
Throughout his career, Ligong Liu has worked with prominent companies in the pharmaceutical industry, including Progen Pharmaceuticals, Inc. and Alchemia Limited. His expertise in drug development and biochemistry has positioned him as a valuable asset in these organizations.
Collaborations
Liu has collaborated with notable colleagues such as Vito Ferro and Tomislav Karoli. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Ligong Liu's innovative work in the field of pharmaceuticals has led to the development of important compounds with potential therapeutic benefits. His contributions continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile